4′-Substituted nucleoside derivatives as inhibitors...

Details 4′-Substituted nucleoside derivatives as inhibitors... 4′-Substituted nucleoside derivatives as inhibitors...

2004-07-15

2009-10-27

Kwon, Brian-Yong S (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S263240, C514S263300, C514S263400, C514S080000

Reexamination Certificate

active

07608601

ABSTRACT:
The present invention relates to the use of nucleoside derivatives of formula Iwherein B signifies a 9-purinyl residue B1 of formulaor a 1-pyrimidyl residue B2 of formulawherein the symbols are as defined in the specification,and of pharmaceutically acceptable salts thereof;for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

REFERENCES:
patent: 3910885 (1975-10-01), Moffat et al.
patent: 5155112 (1992-10-01), Storer et al.
patent: 5192749 (1993-03-01), O-Yang et al.
patent: 5496546 (1996-03-01), Wang et al.
patent: 6479463 (2002-11-01), Wang et al.
patent: 2002/0058635 (2002-05-01), Averett
patent: 0 371 366 (1990-06-01), None
patent: 0 457 326 (1991-11-01), None
patent: 0 799 834 (1997-10-01), None
patent: 6 080 688 (1994-03-01), None
patent: 7126282 (1995-05-01), None
patent: WO 93/17651 (1993-09-01), None
patent: WO 94/01117 (1994-01-01), None
patent: WO 99/43691 (1999-09-01), None
patent: WO 00/69876 (2000-11-01), None
patent: WO 00/69877 (2000-11-01), None
patent: WO 01/43731 (2001-06-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 03/026589 (2003-04-01), None
patent: WO 03/026675 (2003-04-01), None
patent: WO 03039523 (2003-05-01), None
patent: WO 03/062255 (2003-07-01), None
Beyrich-Graf et al., Tetrahedron Letters 39, 1998, 1553-1556.
Maag, et al., “Synthesis and Anti-HIV Activity of 4′-Azido- and 4′ -Methoxynucleosides1”,Journal of Med. Chem., (1992), pp. 1440-1451, vol. 35.
J. G. Moffatt, outline of the synthesis of 4′-azidocytidine from chapter titled “Chemical Transformations of the Sugar Moiety of Nucleosides,” from bookNucleoside Analogues, (1979) p. 144 published by Plenum Press, New York and London.
Jin et al. “Synthesis and Antiviral Activity of Fluoro Sugar Residues on 4′-Azido-2-Deoxy-2′-Fluoro-Arabinofuranosyl Nucleosides,” Arch. Pharm. Res. (1995) pp. 364-365, 18 (5).
Jeon et al., “New Isomeric Analogues of Anti-HIV Active Azidonucleosides,”Tetrahedron(1996) pp. 12643-12649, 52 (39).
Estrada, E. et. al. “In Silico Studies toward the Discovery of new Anti-HIV Nucleoside Compounds with the Use of Tops-Mode and 2D/3D Connectivity Indices. 1. Pyrimidyl Derivatives,”J. Chem. Inf. Computer Sciences, 2002, vol. 42, pp. 1194-1203.
Galisteo, D. et. al. “Conformational comparative analysis of pyrimidine nucleoside derivatives by molecular mechanics calculations and by semiempirical methods (AM1),”J. Molecular Structure, 1996 vol. 384 (1) Abstract.
Kitano, K. et. al. “Synthesis of 4′-C-Fluromethylnucleosides as Potential Antineoplastic Agents,”Tetrahedron, 1997, vol. 53 (39), pp. 13315-13322.
Kodama, E. et. al.—“4′ Ethynyl Nucleoside Analogs: Potent Inhibitors of Multidrug-Resistant Human Immunodeficiency Virus Variants in Vitro,”Antimicrobial Agents and Chem., 2001, vol. 45 (5) p. 1539-1546.
Kohgo, S. et. al. “Synthesis of 4′-C-Ethynyl —β-D-arabino- and 4′-C-Ethynyl-2′ —deoxy- β-D-ribo-pentofuranosyl Pyrimidines, and Their Biological Evaluation,”Biosci. Biotechnology. Biochemistry, 1999,63 (6), pp. 1146-1149.
Nomura, M. et. al. “Nucleosides and Nucleotides. 185. Synthesis and Biological Activities of 4′ α—CBranched-Chain Sugar Pyrimidine Nucleosides,”J. Med. Chem. 1999, vol. 42, pp. 2901-2908.
Pepe, G. et. al. “A Model Allowing the Design of Modified Nucleosides as HIV-RT Inhibitors,”European Journal of Med. Chem., 1996, vol. 31, pp. 775-786.
Yamaguchi, R. et. al. “Synthesis of 4′ -C-Ethynyl-β-D-ribo-pentofuranosyl Pyrimidines,”Biosci. Biotechnol. Biochem. 1999, vol. 63 (3), pp. 736-742.

Affiliated with

Also associated with

Rating

4′-Substituted nucleoside derivatives as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4′-Substituted nucleoside derivatives as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4′-Substituted nucleoside derivatives as inhibitors... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4126048